Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
Stock Price Prediction
Update at 5:00pm EST
1.912 - 1.92
1.92 - 1.928
1.801 - 1.81
1.81 - 1.818
1.866 - 1.88
1.88 - 1.892
as of: 2020-04-09 4:32:37 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.LXRX has closed above bottom band by 49.6%. Bollinger Bands are 67.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to LXRX's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
2020-03-04 Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for Lexicon (LXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2020-01-20 Lexicon Pharmaceuticals : Helena rancher participates in national Young Farmer & Rancher competition Montana Farm Bureau Discussion Meet winner Rocky Forseth competed in two rounds of the national YF&R Discussion Meet during the American Farm Bureau Convention January 18 in Austin….
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.